Candriam Luxembourg S.C.A.
Q3 2020 13F-HR Holdings
Net value change ($000)
+1,171,592
(12.4%)
New positions
52
Sold out positions
45
Turnover %
4.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AMGN | 115,316 | 56.1% |
| MRK | 85,733 | 54.4% |
| BABA | 61,049 | 85.8% |
| DHR | 59,185 | 56.3% |
| TMO | 57,679 | 59.8% |
| QCOM | 43,234 | 125.4% |
| REGN | 38,060 | 26.7% |
| Vivint Solar, Inc. | 35,612 | NEW |
| CSCO | 34,971 | 781.8% |
| Seagen Inc. | 34,759 | 52.3% |
Top Reduces (Value $000, Stocks/ETFs)
| IMMUNOMEDICS INC | -30,957 | -77.4% |
| XOM | -26,438 | -72.5% |
| KMB | -26,390 | -70.7% |
| ANET | -21,716 | -96.6% |
| G1 THERAPEUTICS INC | -21,117 | -100.0% |
| BPMC | -19,036 | -27.8% |
| MRNA | -18,642 | -100.0% |
| BMRN | -17,611 | -38.6% |
| IBERIABANK CORP | -17,046 | -100.0% |
| Meet Group, Inc. | -16,706 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
39,379
(0.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|